These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2586763

  • 1. Experience with continuous enteral levodopa infusions in the treatment of 9 patients with advanced Parkinson's disease.
    Sage JI, Trooskin S, Sonsalla PK, Heikkila RE.
    Neurology; 1989 Nov; 39(11 Suppl 2):60-3; discussion 72-3. PubMed ID: 2586763
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's disease.
    Sage JI, Schuh L, Heikkila RE, Duvoisin RC.
    Clin Neuropharmacol; 1988 Feb; 11(1):36-44. PubMed ID: 3349496
    [Abstract] [Full Text] [Related]

  • 5. The rationale for continuous dopaminergic stimulation in patients with Parkinson's disease.
    Sage JI, Mark MH.
    Neurology; 1992 Jan; 42(1 Suppl 1):23-8; discussion 57-60. PubMed ID: 1347908
    [Abstract] [Full Text] [Related]

  • 6. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease.
    Nyholm D.
    Expert Rev Neurother; 2006 Oct; 6(10):1403-11. PubMed ID: 17078781
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.
    Antonini A, Mancini F, Canesi M, Zangaglia R, Isaias IU, Manfredi L, Pacchetti C, Zibetti M, Natuzzi F, Lopiano L, Nappi G, Pezzoli G.
    Neurodegener Dis; 2008 Oct; 5(3-4):244-6. PubMed ID: 18322402
    [Abstract] [Full Text] [Related]

  • 14. Clinical aspects of motor fluctuations in Parkinson's disease.
    Poewe WH.
    Neurology; 1994 Jul; 44(7 Suppl 6):S6-9. PubMed ID: 8047260
    [Abstract] [Full Text] [Related]

  • 15. Clinical experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease.
    Sage JI, Sonsalla PK, McHale DM, Heikkila RE, Duvoisin RC.
    Adv Neurol; 1990 Jul; 53():383-6. PubMed ID: 2122646
    [No Abstract] [Full Text] [Related]

  • 16. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye GC, Fox T, Fox K, Mancini F, Canesi M, Odin P, Chaudhuri KR.
    Mov Disord; 2009 Jul 30; 24(10):1468-74. PubMed ID: 19425079
    [Abstract] [Full Text] [Related]

  • 17. Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure.
    Nyholm D, Lewander T, Johansson A, Lewitt PA, Lundqvist C, Aquilonius SM.
    Clin Neuropharmacol; 2008 Jul 30; 31(2):63-73. PubMed ID: 18382177
    [Abstract] [Full Text] [Related]

  • 18. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.
    Manson AJ, Turner K, Lees AJ.
    Mov Disord; 2002 Nov 30; 17(6):1235-41. PubMed ID: 12465062
    [Abstract] [Full Text] [Related]

  • 19. Long-term duodenal infusion of levodopa for motor fluctuations in parkinsonism.
    Sage JI, Trooskin S, Sonsalla PK, Heikkila R, Duvoisin RC.
    Ann Neurol; 1988 Jul 30; 24(1):87-9. PubMed ID: 3415201
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study.
    García Ruiz PJ, Sesar Ignacio A, Ares Pensado B, Castro García A, Alonso Frech F, Alvarez López M, Arbelo González J, Baiges Octavio J, Burguera Hernández JA, Calopa Garriga M, Campos Blanco D, Castaño García B, Carballo Cordero M, Chacón Peña J, Espino Ibáñez A, Gorospe Onisalde A, Giménez-Roldán S, Granés Ibáñez P, Hernández Vara J, Ibáñez Alonso R, Jiménez Jiménez FJ, Krupinski J, Kulisevsky Bojarsky J, Legarda Ramírez I, Lezcano García E, Martínez-Castrillo JC, Mateo González D, Miquel Rodríguez F, Mir P, Muñoz Fargas E, Obeso Inchausti J, Olivares Romero J, Olivé Plana J, Otermin Vallejo P, Pascual Sedano B, Pérez de Colosía Rama V, Pérez López-Fraile I, Planas Comes A, Puente Periz V, Rodríguez Oroz MC, Sevillano García D, Solís Pérez P, Suárez Muñoz J, Vaamonde Gamo J, Valero Merino C, Valldeoriola Serra F, Velázquez Pérez JM, Yáñez Baña R, Zamarbide Capdepon I.
    Mov Disord; 2008 Jun 15; 23(8):1130-6. PubMed ID: 18442107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.